MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Mobia Medical, Inc. (MOBI)

Mobia Medical, Inc. (MOBI)

||
||

Cash Flow Overview

Free Cash flow
-$17,210K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Change in fair value of converti...
    • Accrued liabilities and other
    • Others
Negative Cash Flow Breakdown
    • Purchases of property and equipm...
    • Inventory
    • Other assets
    • Others
Cash Flow
2026-06-30
2026-03-31
Net loss
-21,043
-17,740
Depreciation and amortization
135
56
Share-based compensation
1,607
407
Change in fair value of convertible notes payable
-4,142
-728
Change in fair value of warrant liabilities
-221
16
Fair value adjustment of redeemable convertible preferred stock tranche liability
0
-
Amortization of debt discount and debt issuance costs
22
127
Accounts receivable
810
419
Inventory
900
593
Other assets
858
139
Accounts payable
-187
727
Accrued liabilities and other
2,443
-898
Net cash used in operating activities
-15,670
-17,728
Purchases of property and equipment
1,540
42
Net cash used in investing activities
-1,540
-42
Exercise of common stock options
182
358
Proceeds from issuance of common stock in public offering, net
137,501
-
Proceeds from issuance of common stock in warrant exercise
442
-
Proceeds from issuance of convertible notes payable
0
14,102
Proceeds from the related party issuance of convertible notes payable
0
25,898
Proceeds from issuance of series f redeemable convertible preferred stock, net of issuance costs
0
0
Proceeds from the related party issuance of series f redeemable convertible preferred stock, net of issuance costs
0
0
Payment of deferred offering costs
-
450
Net cash provided by financing activities
138,575
39,908
Net change in cash and cash equivalents
121,365
22,138
Cash and cash equivalents, beginning of period
55,725
33,587
Cash and cash equivalents, end of period
177,090
55,725
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock in public...$137,501K Proceeds from issuance ofcommon stock in warrant...$442K Exercise of common stockoptions$182K Net cash provided byfinancing activities$138,575K Net change in cashand cash...$121,365K Canceled cashflow$17,210K Change in fair value ofconvertible notes payable-$4,142K Accrued liabilities andother$2,443K Share-based compensation$1,607K Depreciation andamortization$135K Amortization of debt discountand debt issuance...$22K Net cash used inoperating activities-$15,670K Net cash used ininvesting activities-$1,540K Canceled cashflow$8,349K Net loss-$21,043K Purchases of property andequipment$1,540K Inventory$900K Other assets$858K Accounts receivable$810K Change in fair value ofwarrant liabilities-$221K Accounts payable-$187K